Hormonal
Obesity and type 2 diabetes are independent and joint risk factors for the development of multiple types of cancer, with obesity being the second strongest modifiable risk factor after smoking.
Maintaining a healthy weight and managing blood sugar are critical for cancer prevention. Since obesity is the second strongest modifiable risk factor for cancer after smoking, addressing metabolic health through lifestyle changes or medical management can significantly lower your risk of developing multiple types of cancer.
Obesity and type 2 diabetes (hereafter referred to as diabetes) are both chronic, relapsing, progressive diseases... Obesity is a strong risk factor for the development of diabetes; consequently, half of people diagnosed with diabetes have obesity... Multiple racial and ethnic subgroups experience a disproportionate burden of obesity and diabetes in the US... Obesity and diabetes have long been recognized as risk factors for cardiovascular morbidity and mortality. In 2002, the International Agency for Research on Cancer reported that obesity was linked with the development of five different cancers... In 2016, the International Agency for Research on Cancer and the World Cancer Research Fund reported that obesity was now convincingly linked with the development of 13 different cancers... Furthermore, diabetes has been recognized as a risk factor for the development of multiple malignancies... independent of obesity... After cigarette smoking, obesity is the second strongest modifiable risk factor for cancer.
Why this rating
Based on large-scale epidemiological data, IARC reports, and Mendelian randomization studies cited.
Source
The Triple Health Threat of Diabetes, Obesity, and Cancer—Epidemiology, Disparities, Mechanisms, and Interventions
Justin C. Brown et al. · Obesity · 2021
DOI 10.1002/oby.23161
More from this paper
- The PI3K-Akt-mTOR signaling pathway is a key mechanism linking obesity and diabetes to cancer, as it is sensitive to nutrient status and cell energy states.Strong
- Lifestyle modification resulting in 7% weight loss and 150-175 minutes per week of physical activity can reduce the relative risk of obesity-related cancer by 16%, suggesting the effects of obesity on cancer risk may be reversible.Good
- Metabolic surgery, which yields approximately 25% weight loss at 10 years, is associated with a 44% lower risk of invasive cancer compared to non-surgical patients.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →